Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	150	127	206	148	173.42
Short-Term Investments	828	632	803	351	555.23
Cash & Short-Term Investments	978	759	1,009	499	728.65
Cash Growth	28.85%	-24.78%	102.20%	-31.52%	287.02%
Accounts Receivable	20	38	39	745	1.05
Other Receivables	5	4	4	2	0.65
Receivables	25	42	43	747	1.7
Prepaid Expenses	13	30	15	16	5.47
Total Current Assets	1,016	831	1,067	1,262	735.82
Property, Plant & Equipment	112	143	135	137	23.59
Long-Term Investments	14	107	129	182	6.44
Other Long-Term Assets	8	14	14	11	6.45
Total Assets	1,150	1,095	1,345	1,592	772.29
Accounts Payable	18	17	20	10	15.68
Accrued Expenses	96	62	70	47	27.85
Current Portion of Leases	12	11	3	-	-
Current Income Taxes Payable	1	-	-	2	-
Current Unearned Revenue	85	91	97	102	74.57
Other Current Liabilities	14	3	3	5	3.57
Total Current Liabilities	226	184	193	166	121.67
Long-Term Debt	48	-	-	-	-
Long-Term Leases	99	110	117	117	15.24
Long-Term Unearned Revenue	234	307	355	462	132.53
Other Long-Term Liabilities	58	32	23	5	0.54
Total Liabilities	665	633	688	750	269.99
Common Stock	1,617	1,311	1,206	1,118	0.01
Additional Paid-In Capital	-	-	-	-	830.44
Retained Earnings	-1,132	-849	-542	-275	-328.18
Comprehensive Income & Other	-	-	-7	-1	0.04
Total Common Equity	485	462	657	842	502.3
Shareholders' Equity	485	462	657	842	502.3
Total Liabilities & Equity	1,150	1,095	1,345	1,592	772.29
Total Debt	159	121	120	117	15.24
Net Cash (Debt)	833	745	1,018	564	713.4
Net Cash Growth	11.81%	-26.82%	80.50%	-20.94%	278.93%
Net Cash Per Share	9.25	10.07	14.14	7.62	13.02
Filing Date Shares Outstanding	105.84	90.86	73.01	71.06	70.88
Total Common Shares Outstanding	92.2	75.5	72.9	70.78	65.11
Working Capital	790	647	874	1,096	614.15
Book Value Per Share	5.26	6.12	9.01	11.90	7.71
Tangible Book Value	485	462	657	842	502.3
Tangible Book Value Per Share	5.26	6.12	9.01	11.90	7.71
Machinery	31	27	20	16	11.42
Construction In Progress	1	1	4	2	2.34
Leasehold Improvements	56	54	34	32	11.11

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q